{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:15:38Z","timestamp":1773364538109,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Little is known about the natural history of serrated polyps (SPs), partly due to the lack of large-scale epidemiologic data. In this study, we examined the validity of SP identification according to SNOMED (Systematised Nomenclature of Medicine) codes and free text from colorectal histopathology reports.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Through the ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden) study, we retrieved data on SPs from all pathology departments in Sweden in 2015\u20132017 by using SNOMED codes and free-text search in colorectal histopathology reports. Randomly selected individuals with a histopathology report of SPs were validated against patient charts using a structured, retrospective review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>SPs were confirmed in 101\/106 individuals with a histopathology report of SPs, yielding a positive predictive value (PPV) of 95% (95%CI\u2009=\u200989\u201398%). By year of diagnosis, the PPV was 89% (95%CI\u2009=\u200969\u201397%), 96% (95%CI\u2009=\u200981\u201399%) and 97% (95%CI\u2009=\u200989\u201399%) for individuals diagnosed before 2001 (<jats:italic>n<\/jats:italic>\u2009=\u200919), between 2001 and 2010 (<jats:italic>n<\/jats:italic>\u2009=\u200926) and after 2010 (<jats:italic>n<\/jats:italic>\u2009=\u200961), respectively. According to search method, the PPV for individuals identified by SNOMED codes was 100% (95%CI\u2009=\u200993\u2013100%), and 93% (95%CI\u2009=\u200986\u201397%) using free-text search. Recorded location (colon vs. rectum) was correct in 94% of all SP histopathology reports (95%CI\u2009=\u200984\u201398%) identified by SNOMED codes. Individuals with SPs were classified into hyperplastic polyps (<jats:italic>n<\/jats:italic>\u2009=\u200934; 32%), traditional serrated adenomas (n\u2009=\u20093; 3%), sessile serrated adenomas\/polyps (SSA\/Ps) (<jats:italic>n<\/jats:italic>\u2009=\u200970; 66%), unspecified SPs (n\u2009=\u20093, 3%), and false positive SPs (<jats:italic>n<\/jats:italic>\u2009=\u20095, 5%). For individuals identified by SNOMED codes, SSA\/Ps were confirmed in 49\/52 individuals, resulting in a PPV of 94% (95%CI: 84\u201398%). In total, 57% had \u22652 polyps (1:<jats:italic>n<\/jats:italic>\u2009=\u200944, 2\u20133:<jats:italic>n<\/jats:italic>\u2009=\u200933 and\u2009\u2265\u20094:<jats:italic>n<\/jats:italic>\u2009=\u200927). Some 46% of SPs (<jats:italic>n<\/jats:italic>\u2009=\u200971) originated from the proximal colon and 24% were\u2009\u2265\u200910\u2009mm in size (<jats:italic>n<\/jats:italic>\u2009=\u200937). Heredity for colorectal cancer, intestinal polyposis syndromes, or both was reported in seven individuals (7%). Common comorbidities included diverticulosis (<jats:italic>n<\/jats:italic>\u2009=\u200945, 42%), colorectal cancer (<jats:italic>n<\/jats:italic>\u2009=\u200919, 18%), and inflammatory bowel disease (<jats:italic>n<\/jats:italic>\u2009=\u200910, 9%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Colorectal histopathology reports are a reliable data source to identify individuals with SPs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12876-019-1134-6","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T15:02:51Z","timestamp":1577804571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Validation of serrated polyps (SPs) in Swedish pathology registers"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2862-8855","authenticated-orcid":false,"given":"Soran R.","family":"Bozorg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Emilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"1134_CR1","unstructured":"Regionala cancercentrum i samverkan. Tjock- och \u00e4ndtarmscancer: Nationellt v\u00e5rdprogram. Regionala cancercentrum i samverkan. 2016 [cited 2018 Jan 29]. Available from https:\/\/www.cancercentrum.se\/globalassets\/cancerdiagnoser\/tjock%2D%2Doch-andtarm-anal\/vardprogram\/nvpkolorektalcancer_2016-03-15.pdf."},{"issue":"6","key":"1134_CR2","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/cncr.2820360944","volume":"36","author":"T Muto","year":"1975","unstructured":"Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251\u201370.","journal-title":"Cancer"},{"issue":"2","key":"1134_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ajg.2010.429","volume":"106","author":"CS Huang","year":"2011","unstructured":"Huang CS, Farraye FA, Yang S, O\u2019Brien MJ. The clinical significance of serrated polyps. Am J Gastroenterol. 2011;106(2):229\u201340 quiz 41.","journal-title":"Am J Gastroenterol"},{"key":"1134_CR4","volume-title":"WHO classification of tumours of the digestive system","author":"FT Bosman","year":"2010","unstructured":"Bosman FT. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010."},{"issue":"1","key":"1134_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2559.2006.02549.x","volume":"50","author":"JR Jass","year":"2007","unstructured":"Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50(1):113\u201330.","journal-title":"Histopathology"},{"issue":"1","key":"1134_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gtc.2007.12.014","volume":"37","author":"JE East","year":"2008","unstructured":"East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin N Am. 2008;37(1):25\u201346 v.","journal-title":"Gastroenterol Clin N Am"},{"issue":"4","key":"1134_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1053\/j.gastro.2015.11.046","volume":"150","author":"R Erichsen","year":"2016","unstructured":"Erichsen R, Baron JA, Hamilton-Dutoit SJ, Snover DC, Torlakovic EE, Pedersen L, et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology. 2016;150(4):895\u2013902 e5.","journal-title":"Gastroenterology"},{"key":"1134_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/CLEP.S191914","volume":"11","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Lashkariani M. Cohort profile: ESPRESSO (epidemiology strengthened by histoPathology reports in Sweden). Clin Epidemiol. 2019;11:101\u201314.","journal-title":"Clin Epidemiol"},{"issue":"11","key":"1134_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659\u201367.","journal-title":"Eur J Epidemiol"},{"key":"1134_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"issue":"9","key":"1134_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke HL, Talback M, Hornblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765\u201373.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1134_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02841860802247664","volume":"48","author":"L Barlow","year":"2009","unstructured":"Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27\u201333.","journal-title":"Acta Oncol"},{"issue":"2","key":"1134_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/140349489001800209","volume":"18","author":"S Cnattingius","year":"1990","unstructured":"Cnattingius S, Ericson A, Gunnarskog J, Kallen B. A quality study of a medical birth registry. Scand J Soc Med. 1990;18(2):143\u20138.","journal-title":"Scand J Soc Med"},{"issue":"7","key":"1134_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish prescribed drug register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1134_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Svedberg P, Olen O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423\u201337.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"1134_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Michaelsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125\u201336.","journal-title":"Eur J Epidemiol"},{"key":"1134_CR17","unstructured":"Sergeant ESG. Epitools epidemiological calculators, Sample size to estimate a proportion or apparent prevalence with specified precision. Ausvet Pty Ltd.; 2019 [cited 2019 January 7]. Available from http:\/\/epitools.ausvet.com.au\/content.php?page=1Proportion."},{"key":"1134_CR18","unstructured":"Svensson M, Bergman D, Olen O, Myrelid P, Bohr J, Wickbom A, et al. Validating microscopic colitis (MC) in Swedish pathology registers. Scand J Gastroenterol. 2019:1\u20137."},{"issue":"2","key":"1134_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","volume":"16","author":"LD Brown","year":"2001","unstructured":"Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16(2):101\u201333.","journal-title":"Stat Sci"},{"key":"1134_CR20","unstructured":"Sergeant ESG. Epitools epidemiological calculators, Calculate confidence limits for a sample proportion. Ausvet Pty Ltd.; 2019 [cited 2019 January 7]. Available from http:\/\/epitools.ausvet.com.au\/content.php?page=CIProportion."},{"issue":"5","key":"1134_CR21","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1182\/blood-2005-07-3046","volume":"107","author":"E Beutler","year":"2006","unstructured":"Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747.","journal-title":"Blood"},{"issue":"7","key":"1134_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/gutjnl-2017-314005","volume":"66","author":"JE East","year":"2017","unstructured":"East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66(7):1181\u201396.","journal-title":"Gut"},{"key":"1134_CR23","volume-title":"Pathology and genetics of tumours of the digestive system","author":"SR Hamilton","year":"2000","unstructured":"Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. Lyon: IARC press; 2000."},{"key":"1134_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-230X-9-19","volume":"9","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Brandt L, Montgomery SM, Granath F, Ekbom A. Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol. 2009;9:19.","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"1134_CR25","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1038\/ajg.2010.315","volume":"105","author":"JT Hetzel","year":"2010","unstructured":"Hetzel JT, Huang CS, Coukos JA, Omstead K, Cerda SR, Yang S, et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol. 2010;105(12):2656\u201364.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1134_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1053\/j.gastro.2006.08.038","volume":"131","author":"KJ Spring","year":"2006","unstructured":"Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131(5):1400\u20137.","journal-title":"Gastroenterology"},{"issue":"1","key":"1134_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2559.2005.02180.x","volume":"47","author":"T Higuchi","year":"2005","unstructured":"Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47(1):32\u201340.","journal-title":"Histopathology"},{"issue":"8","key":"1134_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jcp.2010.075507","volume":"63","author":"RH Lash","year":"2010","unstructured":"Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010;63(8):681\u20136.","journal-title":"J Clin Pathol"},{"issue":"6","key":"1134_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/jcp.2008.061960","volume":"62","author":"NJ Carr","year":"2009","unstructured":"Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol. 2009;62(6):516\u20138.","journal-title":"J Clin Pathol"},{"issue":"7","key":"1134_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/aje\/kws282","volume":"177","author":"AN Burnett-Hartman","year":"2013","unstructured":"Burnett-Hartman AN, Passarelli MN, Adams SV, Upton MP, Zhu LC, Potter JD, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol. 2013;177(7):625\u201337.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1134_CR31","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1158\/1055-9965.EPI-09-0211","volume":"18","author":"K Wallace","year":"2009","unstructured":"Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomark Prev. 2009;18(8):2310\u20137.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"1134_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1053\/j.gastro.2016.09.003","volume":"152","author":"L Bailie","year":"2017","unstructured":"Bailie L, Loughrey MB, Coleman HG. Lifestyle risk factors for serrated colorectal polyps: a systematic review and meta-analysis. Gastroenterology. 2017;152(1):92\u2013104.","journal-title":"Gastroenterology"},{"key":"1134_CR33","doi-asserted-by":"crossref","unstructured":"Davenport JR, Su T, Zhao Z, Coleman HG, Smalley WE, Ness RM, et al. Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut. 2016.","DOI":"10.1136\/gutjnl-2016-312893"},{"issue":"4","key":"1134_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bpg.2017.06.004","volume":"31","author":"M Oines","year":"2017","unstructured":"Oines M, Helsingen LM, Bretthauer M, Emilsson L. Epidemiology and risk factors of colorectal polyps. Best Pract Res Clin Gastroenterol. 2017;31(4):419\u201324.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1134_CR35","unstructured":"Folkh\u00e4lsomyndigheten. Folkh\u00e4lsodata. Solna: Folkh\u00e4lsomyndigheten; 2018 [cited 2018 January 7]. Available from http:\/\/fohm-app.folkhalsomyndigheten.se\/Folkhalsodata\/pxweb\/sv\/B_HLV\/B_HLV__aLevvanor__aahLevvanorvikt\/HLV_Viktobmi_alder.px\/table\/tableViewLayout1\/?rxid=b74d8053-7b13-4cfa-8716-aa2a5c66f44c."},{"issue":"1","key":"1134_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cgh.2013.10.035","volume":"13","author":"SD Crockett","year":"2015","unstructured":"Crockett SD, Snover DC, Ahnen DJ, Baron JA. Sessile serrated adenomas: an evidence-based guide to management. Clin Gastroenterol Hepatol. 2015;13(1):11\u201326 e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1134_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cgh.2010.09.013","volume":"9","author":"CJ Kahi","year":"2011","unstructured":"Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;9(1):42\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1134_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-150-1-200901060-00306","volume":"150","author":"NN Baxter","year":"2009","unstructured":"Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1\u20138.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1134_CR39","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa1301969","volume":"369","author":"R Nishihara","year":"2013","unstructured":"Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095\u2013105.","journal-title":"N Engl J Med"},{"issue":"1","key":"1134_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/PAS.0b013e318157f002","volume":"32","author":"EE Torlakovic","year":"2008","unstructured":"Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32(1):21\u20139.","journal-title":"Am J Surg Pathol"},{"key":"1134_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/CLEP.S106257","volume":"9","author":"BM O\u2019Connell","year":"2017","unstructured":"O\u2019Connell BM, Crockett SD. The clinical impact of serrated colorectal polyps. Clin Epidemiol. 2017;9:113\u201325.","journal-title":"Clin Epidemiol"},{"issue":"6","key":"1134_CR42","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1053\/j.gastro.2009.12.066","volume":"138","author":"B Leggett","year":"2010","unstructured":"Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138(6):2088\u2013100.","journal-title":"Gastroenterology"},{"issue":"1","key":"1134_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PAS.0b013e318093e40a","volume":"32","author":"AB Farris","year":"2008","unstructured":"Farris AB, Misdraji J, Srivastava A, Muzikansky A, Deshpande V, Lauwers GY, et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol. 2008;32(1):30\u20135.","journal-title":"Am J Surg Pathol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1134-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-1134-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1134-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T15:55:19Z","timestamp":1665330919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-1134-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-1134-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]},"assertion":[{"value":"5 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Ethical Review Board in Stockholm (July 19, 2017 with reference number: 2017\/1497\u201332).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JFL coordinates a study on behalf of the Swedish IBD quality register (SWIBREG) which has received funding from the Janssen Corporation. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}